TrialDigestive diseases and sciences2019

Second-Generation Biomarker Testing for Irritable Bowel Syndrome Using Plasma Anti-CdtB and Anti-Vinculin Levels.

Walter Morales et al.PubMed ↗Publisher ↗

No numbers read from the abstract.